Development of a Protein Biochip Platform for Parkinson's Disease

Area of Science:

• Biomedical Engineering
• Neuroscience
• Materials Science

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder marked by motor deficits due to dopamine neuron loss.
• Key neuropathological hallmarks include the aggregation of proteins like alpha-synuclein and tau.
• Current diagnostic methods require enhanced sensitivity and accessibility for early detection.

Purpose of the Study:

• To develop a novel biosensor for detecting specific biomolecules associated with Parkinson's disease.
• To explore the potential of conductive polymers for sensitive protein quantification in biological fluids.
• To propose a device for rapid screening and integration into point-of-care diagnostic models for PD.

Main Methods:

• Fabrication of a device utilizing a thin film of acid-doped polyaniline, a conductive polymer.
• Investigation of the polymer's conductivity changes in response to the presence of specific proteins.
• Development of a direct chemical-to-electric transduction method for protein concentration measurement.

Main Results:

• Demonstrated that the conductive polymer film exhibits altered conductivity upon interaction with target proteins.
• Established a direct correlation between protein concentration and changes in electrical conductivity.
• Validated the potential for accurate quantification of biomolecular alterations relevant to PD.

Conclusions:

• The developed polyaniline-based biosensor shows promise for detecting PD-related proteins.
• This technology enables direct, label-free detection and quantification of biomolecules.
• The device is suitable for rapid screening and integration into point-of-care diagnostics for neurodegenerative diseases.